Literature DB >> 15893713

Transient autoimmunity related to maternal autoantibodies: neonatal lupus.

Lela A Lee1.   

Abstract

Neonatal lupus (NLE) is an autoimmune disease associated with maternal antibodies to Ro/La and characterized by cutaneous lesions, heart block, cardiomyopathy, hepatobiliary disease, and hematologic cytopenias. In most cases, only one organ is affected, although multiple organ involvement is not unusual. Since NLE is presumably caused by maternal autoantibodies, the disease process is transient. However, cardiac NLE, in particular, may be fatal or persistently disabling. Optimal therapy has not yet been determined. Mothers of babies with NLE are often initially asymptomatic, but eventually most develop symptoms of autoimmune disease, particularly diseases associated with anti-Ro/La autoantibodies, such as Sjogren's syndrome and systemic lupus erythematosus. Children who have had NLE are probably at increased risk for autoimmunity later in life, sometimes as early as pre-adolescence, but the magnitude of the risk for the children is not known. Only a small percentage of babies exposed to maternal autoantibodies to Ro and/or La develop NLE. The factors governing which babies develop disease and, if disease develops, which organs will be affected have yet to be fully elucidated. In this review the clinical features, diagnosis, therapy, and prognosis of NLE are discussed, and a summary of experimental data relating to pathogenesis is presented.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15893713     DOI: 10.1016/j.autrev.2004.11.003

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  17 in total

1.  Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.

Authors:  Peter M Izmirly; Amit Saxena; Mimi Y Kim; Dan Wang; Sara K Sahl; Carolina Llanos; Deborah Friedman; Jill P Buyon
Journal:  Circulation       Date:  2011-10-03       Impact factor: 29.690

Review 2.  SLE: translating lessons from model systems to human disease.

Authors:  Ram Raj Singh
Journal:  Trends Immunol       Date:  2005-09-09       Impact factor: 16.687

3.  [Skin manifestations in lupus erythematosus: clinical aspects and therapy].

Authors:  A Kuhn; V Ruland; G Bonsmann
Journal:  Z Rheumatol       Date:  2011-04       Impact factor: 1.372

Review 4.  Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases.

Authors:  C Hu; F S Wong; L Wen
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 5.  Complete atrioventricular block in adult Sjögren's syndrome with anti-Ro autoantibody.

Authors:  Myung Jun Sung; Sung-Hoon Park; Seong-Kyu Kim; Young-Soo Lee; Chul-Yeon Park; Jung-Yoon Choe
Journal:  Korean J Intern Med       Date:  2011-06-01       Impact factor: 2.884

6.  A case of neonatal lupus erythematosus showing transient anemia and hepatitis.

Authors:  Kyu Ri Kim; Tae Young Yoon
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

Review 7.  [Connective tissue diseases in childhood].

Authors:  K Gensch; S Gudowius; T Niehues; A Kuhn
Journal:  Hautarzt       Date:  2005-10       Impact factor: 0.751

8.  The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression.

Authors:  T Hung; G A Pratt; B Sundararaman; M J Townsend; C Chaivorapol; T Bhangale; R R Graham; W Ortmann; L A Criswell; G W Yeo; T W Behrens
Journal:  Science       Date:  2015-09-17       Impact factor: 47.728

9.  Neonatal Lupus Erythematosus Presenting as Atypical Targetoid-like Lesions Involving Genitals and Soles of Feet Following Brief Sun Exposure.

Authors:  Shehla Admani; Andrew C Krakowski
Journal:  J Clin Aesthet Dermatol       Date:  2013-05

10.  Rheumatic Disease Autoantibodies in Patients with Autoimmune Thyroid Diseases.

Authors:  Renato Nisihara; Yasmine Gorczevski Pigosso; Nathalia Prado; Shirley R R Utiyama; Gisah A De Carvalho; Thelma L Skare
Journal:  Med Princ Pract       Date:  2018-06-04       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.